Skip to content

Imaging Pathophysiology Study of Whole Body Mitochondrial Function in Diabetic Patients

Imaging Pathophysiology Study of Whole Body Mitochondrial Function in Diabetic Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1041240072
Enrollment
55
Registered
2024-08-20
Start date
2024-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic a healthy person

Interventions

Whole body PET measurements using PET tracer in diabetic and healthy subjects to compare mitochondrial activity based on differences in tracer accumulation in brain, organs and tissues in the two grou

Sponsors

Tsuriya Daisuke
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy persons 1. persons between the ages of 40 and 80 years old 2. Healthy subjects with no history or current history of metabolic, cardiac, or cerebrovascular diseases requiring medical treatment. 3. Persons who have given their consent to participate in this study by signing a consent form. Patients with type 2 diabetes 1.Patients who are between 40 and 80 years old. 2. 2.Patients whose HbA1c is 6.5% or higher. 3. 3. Fasting blood glucose of 126 mg/dL or more or 2-hour blood glucose of 200 mg/dL or more. 4. 4. Patients who have agreed to participate in this study by signing a consent form in person.

Exclusion criteria

Exclusion criteria: 1. healthy people who need to take medication (regular or irregular) that may alter glucose metabolism 2. Women who are pregnant or may become pregnant 3. women who are breastfeeding 4. patients with claustrophobia 5. those with contraindications to MRI (e.g., pacemakers, metals in the body, tattoos) 6. patients with mitochondrial disease, severe liver disease, renal disease, cardiac disease, or cerebrovascular disease 7. who have participated in other nuclear medicine research within one year from the time consent was obtained 8. Other subjects who are judged by the physician to be inappropriate as research subjects.

Design outcomes

Primary

MeasureTime frame
Differences in the distribution of [18F]BCPP-EF accumulation in systemic organ tissues, including the brain, between diabetic and healthy subjects.

Secondary

MeasureTime frame
[18F]BCPP-EF accumulation in systemic organ tissues Background information, 75g OGTT, continuous blood glucose measurement, physical findings, MRI images, neuropsychological examination, clinical laboratory tests, and relationship between NIRS-TRS

Contacts

Public ContactDaisuke Tsuriya

Hamamatsu University Hospital

dtsuri@hama-med.ac.jp+81-53-435-2263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026